The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

SpeedWeed

MAY 1, 2021

The new Cultivar Collection from Trulieve demonstrates how a multi-state player can stay craft at its core. Crafting the Cultivar Collection. The proof is in the pudding with Trulieve’s new Cultivar Collection. Grape Cake from the Cultivar Collection. The Cultivar Collection was no overnight feat.

Collective 52

Collective Trichome Terpenes Strains 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Big Data Improves Distribution in the Marijuana Industry. Source: [link]. Global Cannabis Applications Corp.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

JUNE 1, 2021

The 5-year study is expected to cover tens of thousands of patients suffering from chronic pain, which makes it one of the largest and most ambitious research projects to be conducted in the plant-based treatment arena. has emerged as the largest producer and exporter of legalized cannabis for medical and research applications.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

JANUARY 16, 2024

Let’s take a closer look at this new research around CBD for Cerebral Palsy and examine the extent of this trend and its implications for the future of CP management. It occurs due to abnormalities or damage to the developing brain before, during, or after birth. What is Cerebral Palsy?

Patients 113

Patients CBD Treatment Research and Development 113

Veriheal

FEBRUARY 18, 2021

But it’s acknowledged that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. The university has conducted research that studied the best music to include in psychedelic therapy. Johns Hopkins Explored Which Music Genres Work Best.

Therapy 52

Therapy Research and Development Collective Consumption 52

Cannabis Law Report

DECEMBER 8, 2021

Global Psychiatry Partnering 2014 to 2021 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Access to headline, upfront, milestone and royalty data. Stage of development at signing. Under what conditions can the deal be terminated?

Access 52

Access Data Pharmaceutical Research and Development 52

Cannabis Law Report

JUNE 19, 2022

Partnership will focus on the collection and analysis of digital biomarkers to identify signs of response and relapse in upcoming Phase 2 clinical trials. Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. June 14, 2022 02:00 AM Eastern Daylight Time.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

DECEMBER 23, 2022

Researchers Inspected Cannabis Products for Contaminants. Dr. Maxwell’s team also collected data contained in samples sourced from California. There was more inconsistency in cannabis-borne contaminant regulation as compared with other agricultural commodities,” wrote the researchers. As per the results, 2.3%

Research and Development 92

Research and Development Agriculture Data Extraction 92

The Cannigma

NOVEMBER 11, 2021

Published in the Journal of Clinical Psychopharmacology in September 2021, researchers concluded that CBD could lessen the psychoactive effects of THC when taken together. These conditions are aimed to control any factors that might influence the results, also known as confounding variables. CBD alters the subjective effects of THC.

CBD 139

CBD Research and Development THC Environment 139

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

JUNE 30, 2021

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

AUGUST 2, 2021

Yet, the emerging ecosystem of business opportunities is highly fragmented, and with a lack of institutional capital available, Palo Santo is targeting early-stage, high-growth opportunities within biopharma, drug development, digital therapeutics, healthcare services and tech enabled solutions.

Research and Development 98

Research and Development Therapy Collective Treatment 98

Cannabis Law Report

JUNE 13, 2021

Methods Tissue samples were collected from muscle, brain and hemolymph of Homarus americanus (N=3 per group) following 30 or 60 minutes of exposure to vapor generated by an e-cigarette device using THC (100 mg/mL in a propylene glycol vehicle). THC exposure for 60 minutes had only marginal effect on nociception under the conditions assessed.

THC 100

THC Research and Development History Media 100

SpeedWeed

SEPTEMBER 17, 2021

“Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Puff Puff Post

MARCH 10, 2020

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs. Visit [link].

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

SpeedWeed

AUGUST 11, 2021

According to Dr. Sue Sisley, President of the Scottsdale Research Institute and longtime cannabis researcher, this new study is sorely needed in the community. Veterans are demanding objective cannabis drug development research, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JULY 23, 2021

The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. Research, Training and Prevention. Cannabis research has been limited up to this point due to its status as a Schedule 1 controlled substance.

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

JULY 24, 2022

According to experts, research with psychedelics (also known as hallucinogens) or related substances will increase worldwide in the coming years. Switzerland is a leader in the research and use of psychedelics in psychiatry and is considered an innovation driver in this field. scientific research, (2.) percent annually to $9.8

Research and Development 52

Research and Development Legalization Treatment Patients 52

Puff Puff Post

MARCH 10, 2020

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs. Visit [link].

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

DECEMBER 7, 2021

Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. However, despite the increased use of MCs in children, there is limited data regarding their safety and efficacy in this population for those different indications 11. Data extraction. Introduction.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

AUGUST 27, 2021

Closing of the Private Placement is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including approval of the Toronto Stock Exchange. With a strong focus on research and development, HempFusion Wellness and its family of companies have more than 30 products under development.

Research and Development 105

Research and Development Events Hemp Food 105

Cannabis Law Report

SEPTEMBER 20, 2019

DEA increases the cannabis research quota. Data indicates cannabis-containing vaping products losing market share to other cannabis products after recently reported health concerns. The DEA’s research quotas also include 384,460 grams of tetrahydrocannabinols, 40 grams of LSD, 50 grams of MDMA and 30 grams of psilocybin.

Vaping 40

Vaping Banking Research and Development DEA 40

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. Alongside the Core Business, we remain agile and innovative, developing new solutions to fight the pandemic. In Sweden, Eurofins developed a new automated and robotised PFAS testing method supporting the lowest detection limits globally.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

SEPTEMBER 17, 2021

The closing of the Private Placement has been extended to September 30, 2021 and remains subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including approval of the Toronto Stock Exchange. Follow HempFusion on Twitter , Facebook and Instagram. FORWARD-LOOKING STATEMENTS.

Research and Development 52

Research and Development Events Retail Tincture 52

Cannabis Law Report

JANUARY 4, 2022

Assay and Recently Developed, Unsupervised, At-Home Sample Collection Kit to Expand Addressable Market and Scope of COVID-19 Testing Services – STONY BROOK, N.Y.–(BUSINESS Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. Assay (the “Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

APRIL 14, 2022

Although research is still underway, the effects of both short- and long-term exposure to pesticides by consuming (i.e., Each type of air permit will require certain types of monitoring, recordkeeping, and other conditions that the facility must ensure compliance with, as well as manage changes that may necessitate permit revisions.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

AUGUST 18, 2021

cannabis legalization (or Tilray’s waiver of such condition).In cannabis legalization (or Tilray’s waiver of such condition).In market conditions, future strategic planning, the business and prospects of the MedMen and any other factors that Tilray or the SPV, as applicable, may consider relevant from time to time.?.

Events 105

Events Retail Research and Development Conditions 105

Canna Law Blog

SEPTEMBER 25, 2019

reviewing packaging and labeling of finished products), and for the collection and remittance of cultivation and excise taxes to the California Department of Tax and Fee Administration. 4. Sales, Marketing, Advertising, and Sales Data and Information Rights. Wholesalers can still afford to be picky with distributors in California.

Retail 64

Retail History Packaging Cultivation 64

Cannabis Law Report

AUGUST 17, 2021

cannabis legalization (or Tilray’s waiver of such condition).In A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

Events 105

Events Retail Research and Development Business 105

Cannabis Law Report

JANUARY 21, 2022

Assay”) and Linea™ Unsupervised At-Home Sample Collection Kit (the “Linea Collection Kit”). The Assay previously received conditional approval from the New York State Department of Health in late December 2021. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for its Linea™ 2.0 The Linea 2.0

Collective 52

Collective Therapy Research and Development Supply Chain 52